Company · CIK 0000906709 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
NEKTAR THERAPEUTICS · NKTR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2017 SForm 4 → | Feb 17, 8:03 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 1,457 | $13.14 | $19,145 | 45,022 | −3.13% | plan? |
| Feb 16, 2017 SForm 4 → | Feb 17, 8:02 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 1,261 | $13.14 | $16,570 | 34,504 | −3.53% | plan? |
| Feb 10, 2017 MForm 4 → | Feb 10, 8:11 pm EST | John NicholsonSVP & Chief Operating Officer | 45,000 | $4.65 | $209,250 | 185,326 | — | plan? |
| Feb 8, 2017 SForm 4 → | Feb 10, 8:10 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | $13.04 | $1,141,000 | 177,908 | −33.0% | plan? |
| Feb 8, 2017 MForm 4 → | Feb 10, 8:10 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | $4.65 | $406,875 | 265,408 | — | plan? |
| Feb 2, 2017 SForm 4 → | Feb 6, 5:20 pm EST | John NicholsonSVP & Chief Operating Officer | 75,000 | $12.39 | $929,351 | 140,326 | −34.8% | plan? |
| Feb 2, 2017 MForm 4 → | Feb 6, 5:20 pm EST | John NicholsonSVP & Chief Operating Officer | 75,000 | $4.65 | $348,750 | 148,831 | — | plan? |
| Jan 17, 2017 SForm 4 → | Jan 19, 8:01 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | $12.35 | $1,080,625 | 177,908 | −33.0% | plan? |
| Jan 17, 2017 MForm 4 → | Jan 19, 8:01 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | $4.65 | $406,875 | 265,408 | — | plan? |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:47 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | — | — | 57,602 | — | plan? |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:46 pm EST | Howard W RobinPresident & CEO, Director | 55,000 | — | — | 177,908 | — | plan? |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:45 pm EST | John NicholsonSVP & Chief Operating Officer | 20,000 | — | — | 140,326 | — | plan? |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:45 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 20,000 | — | — | 71,629 | — | plan? |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:44 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 15,000 | — | — | 65,843 | — | plan? |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:43 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 20,000 | — | — | 46,479 | — | plan? |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:42 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 17,500 | — | — | 35,765 | — | plan? |
| Dec 7, 2016 SForm 4 → | Dec 9, 6:03 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | $12.24 | $1,071,000 | 122,908 | −41.6% | plan? |
| Dec 7, 2016 MForm 4 → | Dec 9, 6:03 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | $4.65 | $406,875 | 210,408 | — | plan? |
| Nov 17, 2016 MForm 4 → | Nov 18, 6:12 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | $4.65 | $406,875 | 210,408 | — | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 6:12 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 1,986 | $13.96 | $27,725 | 42,102 | −4.50% | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 6:12 pm EST | Howard W RobinPresident & CEO, Director | 93,458 | $13.88 | $1,296,799 | 122,908 | −43.2% | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 6:11 pm EST | John NicholsonSVP & Chief Operating Officer | 1,654 | $13.96 | $23,090 | 120,326 | −1.36% | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 6:10 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 1,654 | $13.96 | $23,090 | 51,129 | −3.13% | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 6:09 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 1,654 | $13.96 | $23,090 | 50,343 | −3.18% | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 6:08 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 848 | $13.96 | $11,838 | 26,479 | −3.10% | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 6:07 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 670 | $13.96 | $9,353 | 18,265 | −3.54% | plan? |
| Oct 24, 2016 PForm 4 → | Oct 25, 5:00 pm EDT | R Scott GreerDirector | 15,000 | $13.50 | $202,500 | 121,333 | +14.1% | plan? |
| Oct 4, 2016 SForm 4 → | Oct 6, 5:07 pm EDT | Howard W RobinPresident & CEO, Director | 87,500 | $17.06 | $1,492,750 | 128,866 | −40.4% | plan? |
| Oct 4, 2016 MForm 4 → | Oct 6, 5:07 pm EDT | Howard W RobinPresident & CEO, Director | 87,500 | $4.65 | $406,875 | 216,366 | — | plan? |
| Sep 23, 2016 MForm 4 → | Sep 27, 5:09 pm EDT | Roy A WhitfieldDirector | 46,000 | $5.21 | $239,820 | 84,000 | — | plan? |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:14 pm EDT | Dennis L WingerDirector | 8,000 | — | — | 34,250 | — | plan? |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:13 pm EDT | Roy A WhitfieldDirector | 8,000 | — | — | 38,000 | — | plan? |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:12 pm EDT | Lutz LingnauDirector | 8,000 | — | — | 30,450 | — | plan? |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:11 pm EDT | Christopher A KueblerDirector | 8,000 | — | — | 35,500 | — | plan? |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:11 pm EDT | Joseph J KrivulkaDirector | 8,000 | — | — | 58,000 | — | plan? |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:10 pm EDT | R Scott GreerDirector | 8,000 | — | — | 106,333 | — | plan? |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:09 pm EDT | Robert ChessDirector | 8,000 | — | — | 271,623 | — | plan? |
| Sep 16, 2016 SForm 4 → | Sep 19, 5:15 pm EDT | Christopher A KueblerDirector | 7,500 | $19.13 | $143,475 | 27,500 | −21.4% | plan? |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:17 pm EDT | Dennis L WingerDirector | 15,000 | — | — | 26,250 | — | plan? |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:16 pm EDT | Roy A WhitfieldDirector | 15,000 | — | — | 30,000 | — | plan? |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:16 pm EDT | Lutz LingnauDirector | 15,000 | — | — | 22,450 | — | plan? |
| Sep 15, 2016 SForm 4 → | Sep 19, 5:16 pm EDT | Lutz LingnauDirector | 9,000 | $19.06 | $171,540 | 7,450 | −54.7% | plan? |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:15 pm EDT | Christopher A KueblerDirector | 15,000 | — | — | 35,000 | — | plan? |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:14 pm EDT | Joseph J KrivulkaDirector | 15,000 | — | — | 50,000 | — | plan? |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:14 pm EDT | R Scott GreerDirector | 15,000 | — | — | 98,333 | — | plan? |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:13 pm EDT | Robert ChessDirector | 15,000 | — | — | 263,623 | — | plan? |
| Sep 15, 2016 SForm 4 → | Sep 19, 5:13 pm EDT | Robert ChessDirector | 12,000 | $19.21 | $230,520 | 248,623 | −4.60% | plan? |
| Sep 1, 2016 SForm 4 → | Sep 2, 8:03 pm EDT | Howard W RobinPresident & CEO, Director | 87,500 | $17.83 | $1,560,125 | 128,886 | −40.4% | plan? |
| Sep 1, 2016 MForm 4 → | Sep 2, 8:03 pm EDT | Howard W RobinPresident & CEO, Director | 87,500 | $4.65 | $406,875 | 216,366 | — | plan? |
| Aug 16, 2016 SForm 4 → | Aug 17, 5:45 pm EDT | John NicholsonSVP & Chief Operating Officer | 3,317 | $17.56 | $58,247 | 121,980 | −2.65% | plan? |
| Aug 16, 2016 SForm 4 → | Aug 17, 5:42 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 3,971 | $17.56 | $69,731 | 44,088 | −8.26% | plan? |
| Aug 16, 2016 SForm 4 → | Aug 17, 5:41 pm EDT | Howard W RobinPresident & CEO, Director | 11,817 | $17.56 | $207,507 | 128,866 | −8.40% | plan? |
| Aug 16, 2016 SForm 4 → | Aug 17, 5:39 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 3,305 | $17.56 | $58,036 | 52,783 | −5.89% | plan? |
| Aug 16, 2016 SForm 4 → | Aug 17, 5:38 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 3,305 | $17.56 | $58,036 | 51,997 | −5.98% | plan? |
| Aug 16, 2016 SForm 4 → | Aug 17, 5:38 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 1,685 | $17.56 | $29,589 | 27,327 | −5.81% | plan? |
| Aug 16, 2016 SForm 4 → | Aug 17, 5:37 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 1,336 | $17.56 | $23,460 | 18,935 | −6.59% | plan? |
| Aug 1, 2016 SForm 4 → | Aug 3, 7:01 pm EDT | Robert ChessDirector | 5,000 | $17.26 | $86,300 | 260,623 | −1.88% | plan? |
| Aug 1, 2016 MForm 4 → | Aug 3, 7:01 pm EDT | Robert ChessDirector | 5,000 | $5.15 | $25,750 | 265,623 | — | plan? |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:10 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 22,500 | — | — | 29,309 | — | plan? |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:09 pm EDT | Howard W RobinPresident & CEO, Director | 67,500 | — | — | 84,843 | — | plan? |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:08 pm EDT | John NicholsonSVP & Chief Operating Officer | 26,000 | — | — | 103,630 | — | plan? |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:07 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 26,000 | — | — | 34,421 | — | plan? |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:06 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 26,000 | — | — | 32,735 | — | plan? |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:05 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 15,000 | — | — | 16,521 | — | plan? |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:04 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 10,500 | — | — | 11,521 | — | plan? |
| Jul 11, 2016 SForm 4 → | Jul 13, 5:08 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 100,000 | $15.09 | $1,509,000 | 6,809 | −93.6% | plan? |
| Jul 11, 2016 MForm 4 → | Jul 13, 5:08 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 100,000 | $4.65 | $465,000 | 106,809 | — | plan? |
| Jul 1, 2016 SForm 4 → | Jul 5, 5:21 pm EDT | Robert ChessDirector | 5,000 | $14.10 | $70,500 | 260,623 | −1.88% | plan? |
| Jul 1, 2016 MForm 4 → | Jul 5, 5:21 pm EDT | Robert ChessDirector | 5,000 | $5.15 | $25,750 | 265,623 | — | plan? |
| Jun 1, 2016 SForm 4 → | Jun 3, 5:05 pm EDT | Robert ChessDirector | 5,000 | $15.50 | $77,500 | 260,623 | −1.88% | plan? |
| Jun 1, 2016 MForm 4 → | Jun 3, 5:05 pm EDT | Robert ChessDirector | 5,000 | $5.15 | $25,750 | 265,623 | — | plan? |
| May 17, 2016 SForm 4 → | May 18, 5:23 pm EDT | John NicholsonSVP & Chief Financial Officer | 856 | $13.58 | $11,624 | 77,630 | −1.09% | plan? |
| May 17, 2016 SForm 4 → | May 18, 5:23 pm EDT | Howard W RobinPresident & CEO, Director | 2,170 | $13.58 | $29,469 | 16,933 | −11.4% | plan? |
| May 17, 2016 SForm 4 → | May 18, 5:15 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 339 | $13.58 | $4,604 | 1,021 | −24.9% | plan? |
| May 17, 2016 SForm 4 → | May 18, 5:14 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 432 | $13.58 | $5,867 | 1,512 | −22.2% | plan? |
| May 17, 2016 SForm 4 → | May 18, 5:13 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 835 | $13.58 | $11,339 | 7,135 | −10.5% | plan? |
| May 17, 2016 SForm 4 → | May 18, 5:12 pm EDT | Gil M LabrucherieSVP & General Counsel | 836 | $13.58 | $11,353 | 7,921 | −9.55% | plan? |
| May 17, 2016 SForm 4 → | May 18, 5:08 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 724 | $13.58 | $9,832 | 6,309 | −10.3% | plan? |
| May 16, 2016 MForm 4 → | May 18, 5:23 pm EDT | John NicholsonSVP & Chief Financial Officer | 2,167 | $0.0001 | $0 | 78,486 | — | plan? |
| May 16, 2016 MForm 4 → | May 18, 5:23 pm EDT | Howard W RobinPresident & CEO, Director | 5,625 | $0.0001 | $1 | 19,103 | — | plan? |
| May 16, 2016 MForm 4 → | May 18, 5:15 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 875 | $0.0001 | $0 | 1,360 | — | plan? |
| May 16, 2016 MForm 4 → | May 18, 5:14 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 1,250 | $0.0001 | $0 | 1,944 | — | plan? |
| May 16, 2016 MForm 4 → | May 18, 5:13 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 2,167 | $0.0001 | $0 | 7,970 | — | plan? |
| May 16, 2016 MForm 4 → | May 18, 5:12 pm EDT | Gil M LabrucherieSVP & General Counsel | 2,167 | $0.0001 | $0 | 8,757 | — | plan? |
| May 16, 2016 MForm 4 → | May 18, 5:08 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 1,875 | $0.0001 | $0 | 7,033 | — | plan? |
| Apr 25, 2016 SForm 4 → | Apr 27, 5:08 pm EDT | Lutz LingnauDirector | 15,000 | $16.27 | $244,050 | 16,450 | −47.7% | plan? |
| Apr 25, 2016 MForm 4 → | Apr 27, 5:08 pm EDT | Lutz LingnauDirector | 15,000 | $8.37 | $125,550 | 31,450 | — | plan? |
| Mar 9, 2016 SForm 4 → | Mar 11, 5:06 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | $11.79 | $176,850 | 5,158 | −74.4% | plan? |
| Mar 9, 2016 MForm 4 → | Mar 11, 5:06 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | $6.65 | $99,750 | 20,158 | — | plan? |
| Feb 17, 2016 SForm 4 → | Feb 18, 7:49 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 556 | $11.92 | $6,628 | 694 | −44.5% | plan? |
| Feb 17, 2016 SForm 4 → | Feb 18, 7:48 pm EST | John NicholsonSVP & Chief Financial Officer | 963 | $11.92 | $11,479 | 76,319 | −1.25% | plan? |
| Feb 17, 2016 SForm 4 → | Feb 18, 7:48 pm EST | Howard W RobinPresident & CEO, Director | 2,147 | $11.92 | $25,592 | 13,478 | −13.7% | plan? |
| Feb 17, 2016 SForm 4 → | Feb 18, 7:47 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 390 | $11.92 | $4,649 | 485 | −44.6% | plan? |
| Feb 17, 2016 SForm 4 → | Feb 18, 7:46 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 716 | $11.92 | $8,535 | 5,158 | −12.2% | plan? |
| Feb 17, 2016 SForm 4 → | Feb 18, 7:45 pm EST | Gil M LabrucherieSVP & General Counsel | 827 | $11.92 | $9,858 | 6,590 | −11.2% | plan? |
| Feb 17, 2016 SForm 4 → | Feb 18, 7:45 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 963 | $11.92 | $11,479 | 5,803 | −14.2% | plan? |
| Feb 16, 2016 MForm 4 → | Feb 18, 7:49 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 1,250 | $0.0001 | $0 | 1,250 | — | plan? |
| Feb 16, 2016 MForm 4 → | Feb 18, 7:48 pm EST | John NicholsonSVP & Chief Financial Officer | 2,166 | $0.0001 | $0 | 77,282 | — | plan? |
| Feb 16, 2016 MForm 4 → | Feb 18, 7:48 pm EST | Howard W RobinPresident & CEO, Director | 5,625 | $0.0001 | $1 | 15,625 | — | plan? |
| Feb 16, 2016 MForm 4 → | Feb 18, 7:47 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 875 | $0.0001 | $0 | 875 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2015 AForm 4 → | Sep 17, 5:15 pm EDT | Joseph J KrivulkaDirector | 27,500 | — | — | 15,000 | — | |
| Sep 15, 2015 AForm 4 → | Sep 17, 5:13 pm EDT | R Scott GreerDirector | 27,500 | — | — | 15,000 | — | |
| Sep 15, 2015 AForm 4 → | Sep 17, 5:12 pm EDT | Robert ChessDirector | 27,500 | — | — | 15,000 | — | |
| Sep 11, 2015 MForm 4 → | Sep 15, 4:12 pm EDT | Roy A WhitfieldDirector | 15,000 | $8.81 | $132,150 | 0 | — | |
| Aug 13, 2015 MForm 4 → | Aug 17, 4:04 pm EDT | Gil M LabrucherieSVP & General Counsel | 33,333 | — | — | 133,333 | — | |
| Aug 13, 2015 MForm 4 → | Aug 17, 4:03 pm EDT | Howard W RobinPresident & CEO, Director | 58,333 | — | — | 583,333 | — | |
| Aug 11, 2015 MForm 4 → | Aug 13, 5:10 pm EDT | John NicholsonSVP & Chief Financial Officer | 385,000 | — | — | 0 | — | |
| Jul 24, 2015 MForm 4 → | Jul 28, 4:06 pm EDT | Joseph J KrivulkaDirector | 15,000 | — | — | 0 | — | |
| Jul 14, 2015 MForm 4 → | Jul 16, 4:16 pm EDT | Howard W RobinPresident & CEO, Director | 58,334 | — | — | 641,666 | — | |
| Jul 14, 2015 MForm 4 → | Jul 16, 4:14 pm EDT | Gil M LabrucherieSVP & General Counsel | 33,334 | — | — | 166,666 | — | |
| Jun 29, 2015 MForm 4 → | Jul 1, 4:09 pm EDT | Susan WangDirector | 30,000 | — | — | 0 | — | |
| Jun 19, 2015 MForm 4 → | Jun 23, 4:05 pm EDT | Robert ChessDirector | 15,000 | — | — | 0 | — | |
| Jun 15, 2015 MForm 4 → | Jun 17, 4:07 pm EDT | Lutz LingnauDirector | 25,000 | — | — | 12,500 | — | |
| Jan 13, 2015 MForm 4 → | Jan 15, 5:54 pm EST | Christopher A KueblerDirector | 15,000 | — | — | 0 | — |